Birmingham, AL, United States of America

Steven L McCune

This inventor holds 4 USPTO granted patents. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven L McCune. Retrieved from https://idiyas.com/inventor/steven-l-mccune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Steven L McCune

Introduction

Steven L McCune is a prominent inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical therapeutics, particularly in the area of sickle cell anemia. With a total of 4 patents to his name, McCune's work is recognized for its potential impact on patient care and treatment options.

Latest Patents

Among his latest innovations, McCune has developed anti-sickling human hemoglobins. These hemoglobins are disclosed for use as therapeutics in treating sickle cell anemia. His research aims to provide new solutions for individuals affected by this challenging condition.

Career Highlights

McCune is affiliated with the UAB Research Foundation at the University of Alabama at Birmingham. His role at this esteemed institution allows him to collaborate with other leading researchers and contribute to groundbreaking medical advancements.

Collaborations

One of his notable collaborators is Tim M Townes. Together, they work on innovative projects that aim to improve the lives of those suffering from sickle cell anemia.

Conclusion

Steven L McCune's contributions to medical research and innovation highlight the importance of dedicated inventors in the field of healthcare. His work continues to inspire advancements that may lead to better treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…